| 标题 |
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial 口服小分子GLP-1受体激动剂Orforglipron治疗2型糖尿病患者肥胖(ATTAIN-2):一项3期、双盲、随机、多中心、安慰剂对照试验
|
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Deborah B Horn; Donna H Ryan; Sanja Giljanovic Kis; Breno Alves; Yiming Mu; et al 出版日期:2025 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |